Costs of treatment and prevention could potentially be offset by cutting direct medical costs, authors say
MONDAY, April 5, 2021 (HealthDay News) — Annual medical costs associated with substance use disorder (SUD) in U.S. emergency departments and inpatient settings exceeded $13 billion in 2017, according to a study published online March 5 in JAMA Network Open.
Cora Peterson, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues estimated the annual attributable medical cost of SUD in U.S. hospitals using nationally representative hospital emergency department (124,573,175 encounters) and inpatient encounters (33,648,910) identified from the 2017 Healthcare Cost and Utilization Project Nationwide Emergency Department Sample and National Inpatient Sample.
The researchers found that total annual estimated attributable SUD medical cost in hospitals was $13.2 billion. The cost ranged by substance type from $4 million for inhalant-related disorders to $7.6 billion for alcohol-related disorders. Approximately 4 percent of all hospital emergency department encounters had an SUD diagnosis (principal or secondary), as did approximately 10 percent of all hospital inpatient encounters.
“This study’s results suggest that the cost of effective prevention and treatment may be substantially offset by a reduction in the high direct medical cost of SUD hospital care,” the authors write.
ED Visits, Hospitalizations for Alcohol, Cannabis Vary by Age 
Hospital Outcomes Better When Patients Treated by Female Physicians 
Rates of Pediatric E-Bicycle, E-Scooter Injuries Increasing 
Withdrawal From Medetomidine Increasingly Seen in ICUs .jpg)
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder 
Study Looks at Patient Experiences With Sedative Contaminating Fentanyl 
Multicomponent Interventions Offer Little Impact on Fall Risk 
ED Visits for Gambling Disorder Spike After Canada Liberalizes Online Gambling 
